Transforming the clinical trial process: The I-SPY 2 trial as a model for improving the efficiency of clinical trials and accelerating the drug-screening process.
暂无分享，去创建一个
D. Berry | L. Esserman | N. Hylton | D. Yee | W. Symmans | M. Hogarth | A. DeMichele | J. Perlmutter | M. Paoloni | M. Buxton | J. Lyandres | S. E. Davis | S. Flynn | L. Veer | Kelsey H. Natsuhara